Piotr Hallmann is the latest member of the UFC’s active roster to fail a post-fight drug test, as the he was found to have performance-enhancing drugs in his system following UFC Fight Night 51.
Hallmann’s test came back positive for Drostanolone after losing a split decision to Gleison Tibau in the co-main event. While the result will stay the same, Hallmann will lose his $50,000 “Fight of the Night” bonus and also be suspended nine months and fined.
The CABMMA, the head athletic commission out of Brazil where the event took place, released a statement regarding the matter:
The Brazilian MMA Athletic Commission (CABMMA) advises that all fighters were subjected to doping control tests for the presence of anabolic agents, diuretics / masking agents, stimulants and cannabinoids at UFC Fight Night: Bigfoot vs Arlovski, held in Brasilia / DF on September 13, 2014. Four athletes were randomly selected for testing erythropoietin (EPO) levels and growth hormone (HGH).
The athlete Piotr Hallman tested positive for the anabolic steroid drostanolone present. He will be suspended for nine months, retroactive to the date of the fight. To license professional wrestler in CABMMA again, the athlete will need to carry out further tests of anti-doping control.
The Brazilian MMA Athletic Commission (CABMMA) conducted all tests in a laboratory accredited by WADA.